öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÐܾýÓî
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º30

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºjyxiong0639@163.com


¸öÈ˼òÊö :
ÐܾýÓî 1959Äê5Ô³öÉú£¬ÄУ¬1983Äê8ÔÂÖйúÒ½¿Æ´óѧҽѧϵ±ÏÒµ¡£ÔÚְ˶ʿÑо¿Éú±ÏÒµ¡£ÔÚÖйúÒ½¿Æ´óѧ¸½ÊôÒ»ÔºÂé×í¿Æ£¬×öסԺҽÉú£¬½²Ê¦£¬¸±½ÌÊÚ£¬2001Äê½úÉý½ÌÊÚ¡£2002Ä꿪ʼ£¬¾ÍÖ°ÓÚ´óÁ¬Ò½¿Æ´óѧµÚ¶þÁÙ´²Ñ§Ôº Âé×í½ÌÑÐÊÒÖ÷ÈΣ¬Âé×í¿ÆÖ÷ÈΣ»½ÌÊÚ£¬Ö÷ÈÎҽʦ£»Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£2012Ä격ʿÑо¿Éúµ¼Ê¦¡£1987ÄêÔÚ±±¾©¸·ÍâÒ½ÔºÂé×í¿Æ½øÐÞ. 1994ÄêÖÁ1995ÄêÔÚÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽҽѧԺÂé×í¿Æ´ÓʦDr.Sessler, Ñо¿Ìåμà²âÓëÌåε÷½Ú¡£ÖлªÒ½Ñ§»áÂé×íѧ·Ö»áµÚÊ®½ìίԱ»áÈ«¹úίԱ¡£ÊÀ½çÌÛʹҽʦЭ»áÖйú·Ö»á³£Î¯¡£ÖлªÒ½Ñ§»áÁÉÄþÊ¡Âé×íѧ·Ö»á¸±Ö÷ί¡£ÁÉÄþÊ¡Âé×íÖÊÁ¿¿ØÖÆÖÐÐĸ±Ö÷ÈΡ£ÖлªÒ½Ñ§»áÁÉÄþÊ¡ÌÛʹѧ»á³£Î¯¡£´óÁ¬ÊÐÂé×íÖÊÁ¿¿ØÖÆÖÐÐÄר¼ÒίԱ»áÖ÷ÈΡ£ÖлªÒ½Ñ§»á´óÁ¬ÊÐÂé×íѧ·Ö»á¸±Ö÷ί¡£¡¶ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾¡·±àί¡£¡¶´óÁ¬Ò½¿Æ´óѧѧ±¨¡· ±àί¡£¡¶¹ú¼ÊÂé×íÓ븴ËÕÔÓÖ¾¡·±àί¡£¡¶ÖлªÂé×íѧÔÓÖ¾¡·Í¨Ðűàί¡£¡¶Âé×íÓë¼à²âÂÛ̳¡·ÔÓÖ¾±àί¡£ÏȺó»ñµÃÊ¡¼¶¿ÆÑлù½ð3Ï»ñ¹ú¼Ò×ÔÈ»»ù½ðÒ»ÏÑо¿¾­·Ñ´ï°ÙÍòÔª¡£Ö÷Òª´ÓÊÂΧÊÖÊõÆÚÆ÷¹Ù±£»¤Ñо¿¡£ÏȺ󷢱íSCIÂÛÎÄ6ƪ£¬µÚÒ»×÷ÕßÎÄÕµı»Òý´ï70´ÎÒÔÉÏ¡£ÔÚ¹úÄÚ·¢±íÂÛÎÄ30Óàƪ¡£»ñµÃרÀûÒ»Ïî¡£Ö÷±àÊÓÌý½Ì²ÄÒ»²¿¡£¸±Ö÷±àÖø×÷Ò»²¿¡£´ÓÊÂÁÙ´²Âé×í¹¤×÷½ü30Ä꣬°üÀ¨£¬ÆÕÍâ¿Æ¡¢¹ÇÍâ¿Æ¡¢ÃÚÄòÍâ¿Æ¡¢¸¾¿Æ¡¢ÐØÍâ¿Æ¡¢Éñ¾­Íâ¿ÆºÍÐÄÔàÍâ¿ÆÌåÍâÑ­»·µÄÂé×í´¦Àí¡£ÌرðÔÚ¸ÎÒÆÖ²£¬ÒÈÉöÁªºÏÒÆÖ²£¬¹¦ÄÜÉñ¾­Íâ¿Æ£¬´óѪ¹ÜÊÖÊõ£¬ÒÔ¼°Î£ÖØÖ¢ÊÖÊõµÄÂé×íÆÀ¹ÀºÍÂé×í´¦Àí·½ÃæÓÐ×ŷḻµÄ¾­Ñé¡£

¿ÆÑй¤×÷ :
¹ú¼Ò×ÔÈ»»ù½ðÒ»ÏîÏîÄ¿Åú×¼ºÅ£º**ÏîÄ¿Ãû³Æ£º¾²ÂöÂé×íÒ©ÒÀÍÐßäõ¥¿¹Å§¶¾Ö¢Ìõ¼þÏÂÉöÉÏÏÙËðÉË»úÖÆÑо¿×ÊÖú½ð¶î£º58ÍòÔªÖ÷³ÖÈË
·¢±íÂÛÎÄ1£®Etomidate increases mortality in septic rats through inhibition of nuclear factor kappa-B rather than by causing adrenal insufficiency IF 2.01ͨѶ×÷Õß
2£®Pretreatment with low dose etomidate preventsetomidate-induced rat adrenal insufficiency byregulating oxidative stress-related MAPKs andapoptosis IF2.2ͨѶ×÷Õß
3£®Effects of propofol and etomidate pretreatment on glucocorticoid receptor expression following induction of sepsis in rats Genet Mol Res IF0.775ͨѶ×÷Õß
4£®The pituitary adenylate cyclase-activating polypeptide (PACAP) protects adrenal function in septic rats administered etomidate(ETO) Neuropeptides IF 2.61ͨѶ×÷Õß
5£®Etomidate Mitigates Lipopolysaccharide-Induced CD14 and TREM-1 Expression, NF-¦ÊB Activation,?and Pro-inflammatory Cytokine Production in Rat Macrophages Inflammation, Vol. 39, No. 1, February 2016 IF 2.6ͨѶ×÷Õß
6£®ÒÀÍÐßäõ¥Ô¤´¦Àí¶ÔÒÀÍÐßäõ¥ÓÕµ¼´óÊóÉöÉÏÏÙƤÖÊϸ°û¶¾ÐÔµÄÓ°Ï죺ÀëÌåʵÑé ÖлªÂé×íѧÔÓÖ¾ 2015Äê ͨѶ×÷Õß
7£®ÒÀÍÐßäõ¥¶ÔÖíÉöÉÏÏÙƤÖÊϸ°ûµÄ¶¾ÐÔ×÷Óü°ÒÀÍÐßäõ¥Ô¤´¦Àí¶ÔÆäµÄÓ°Ïì ÖлªÂé×íѧÔÓÖ¾ 2010Äê ͨѶ×÷Õß
8£®ÒÀÍÐßäõ¥Ô¤´¦Àí¶Ô HLÒ» 60 ϸ°ûµòÍöÏà¹Øµ°°×±í´ïµÄÓ°Ïì ÖлªÂé×íѧÔÓÖ¾ 2010ÄêͨѶ×÷Õß
9£®ÂÞßß¿¨ÒòÔ¤´¦Àí¶ÔÆäÓÕµ¼ ND7£¯ 23 ϸ°û¶¾ÐÔµÄÓ°Ïì ÖлªÂé×íѧÔÓÖ¾ 2011ÄêͨѶ×÷Õß
10£®°±¼×»·Ëá¶ÔÀÏÄêÈ«÷ŹؽÚÖû»Êõ»¼ÕßµÄѪҺ±£»¤Ð§¹ûÖлªÂé×íѧÔÓÖ¾ 2012ÄêͨѶ×÷Õß